Approval · Notice of Compliance 25845 · 2021
AMOXICILLIN: Notice of Compliance 25845
Issued May 10, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25845
- Date
- May 10, 2021
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Updating the product monograph. labelling update to match licensor
- Canadian reference product
- APO-AMOXI (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMOXICILLIN | Not yet assigned | — |
Medicinal ingredients
- AMOXICILLIN 500 MG per CAP